Positive revenues and profits have been reported and look at where the stock price is at. I'm saying that the share price wasn't able to even maintain a 2 cent pps but somehow a 50:1 reverse stock split is somehow now going to draw positive attention to the company and attract deep pocket investors????? I don't think so.
The Typical OTC dilution rinse and repeat RS business model does not apply to BRAV.
It is an illogical assumption to lump a growing company having revenue, net profits and a conservative CEO with the typical CEO share selling scam company model.
News 
Market Data 
Discover 
AI
